CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 316 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $2,985,000 | +4.4% | 45,000 | +9.9% | 0.07% | +17.7% |
| Q2 2014 | $2,859,000 | -4.9% | 40,950 | -0.4% | 0.06% | +3.3% |
| Q1 2014 | $3,006,000 | -5.3% | 41,100 | -10.8% | 0.06% | -13.0% |
| Q4 2013 | $3,174,000 | -28.6% | 46,080 | -34.2% | 0.07% | +43.8% |
| Q3 2013 | $4,448,000 | +53.5% | 70,000 | +16.7% | 0.05% | -43.5% |
| Q2 2013 | $2,897,000 | – | 60,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
| HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
| SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
| Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
| PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
| Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
| Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |